When should academic papers be censored due to public health/safety concerns? A recent paper in the Journal of Infectious Diseases, which reports the discovery of a new botulinum toxin, has been censored:


  Because no antitoxins as yet have been developed to counteract the novel C. Botulinum toxin, the authors had detailed consultations with representatives from numerous appropriate US government agencies.


The team sequenced the bacterial DNA corresponding to the toxin, but did not publish it.

I can understand the reasoning, and see how it might make sense, but I wondered: in such a case, what are guidelines that should be followed? The editors indicate consultations with governmental agencies, but I think the government might in some case be overly eager to censor data that should, from an ethical and moral point of view, be disseminated.

So, without turning this into a political question: what are guidelines (written rules as well as unwritten moral standards) that an author, reviewer or editor should follow concerning potential public safety issues? I looked for information on the COPE website, but could not really find anything relevant.
This is a rising bioethics topic in the area of biosecurity and dual-use developments. Last year there was controversy with H5N1 and censorship.

There is no set policy, though they are being devolped. Most recently there is the United States Government Policy for Institutional Oversight of Life Sciences Dual Use Research of Concern

The IAP Statement On Biosecurity principles state:


  Awareness. Scientists have an obligation to do no harm. They should
  always take into consideration the reasonably foreseeable consequences
  of their own activities. They should therefore:
  
  
  always bear in mind the potential consequences – possibly harmful – of their research and recognize that individual good conscience does
  not justify ignoring the possible misuse of their scientific
  endeavour;
  refuse to undertake research that has only harmful consequences for humankind.
  


The US NIH Office of Biotechnology Activities is often consulted for such research concerns and has a report Enhancing Responsible Science Considerations for the Development and Dissemination of Codes of Conduct for Dual Use Research and has a series of recommendations.

The WHO Laboratory Biosafety Manual does not address publication restrictions/censorship.